文献速递头颈神经MR

对比增强眼眶MRI用于甲状腺眼病活动度评估与治疗反应预测

Contrast-enhanced orbital MRI for activity assessment and treatment response prediction in thyroid eye disease.
PubMed 文献 · Eur J Radiol · 2025-04-26

回顾性纳入59例活动期中重度甲状腺眼病(TED)患者(36例对静脉糖皮质激素治疗有反应、23例无反应)及31例非活动期TED患者,采集T1加权对比增强(T1CE)与动态对比增强MRI(DCE-MRI)。活动期患者外直肌信号强度比(LR-SIR)与下直肌流入率(IR-WIR)较高,联合模型AUC达0.914。有反应患者外直肌达峰时间(LR-TTP)较长,预测模型AUC为0.739。

要点

  • 联合LR-SIR与IR-WIR的模型评估TED活动度AUC为0.914(95%CI 0.858-0.970)。
  • T1CE模型与DCE-MRI模型评估活动度AUC分别为0.866与0.844。
  • 预测IVGC治疗反应的模型AUC为0.739(95%CI 0.608-0.807),预测概率截断值0.678。

核心结论

  • T1CE与DCE-MRI可有效辅助TED活动度评估,DCE-MRI可帮助预测IVGC治疗反应;LR-SIR与IR-WIR为TED活动度指标,IR-TTP可预测IVGC治疗反应;联合两种对比增强序列可进一步提高活动度评估效能。

研究设计与样本

  • 回顾性研究,纳入59例接受IVGC治疗的活动期中重度TED患者(36例有反应、23例无反应)及31例非活动期TED患者,采集T1CE与DCE-MRI,采用单因素及多因素logistic回归与ROC曲线(AUC)评估诊断与预测模型。

关键影像表现/征象

  • 活动期患者T1CE上外直肌信号强度比(LR-SIR)高于非活动期患者(p<0.05)。
  • 活动期患者DCE-MRI上下直肌流入率(IR-WIR)高于非活动期患者(p<0.05)。
  • 对IVGC有反应患者外直肌达峰时间(LR-TTP)长于无反应患者(p<0.05)。

诊断标准与关键数值

  • 基于T1CE的模型评估TED活动度AUC为0.866。
  • 基于DCE-MRI的模型评估TED活动度AUC为0.844。
  • 联合LR-SIR与IR-WIR的模型评估TED活动度AUC为0.914(95%CI 0.858-0.970)。
  • 预测IVGC治疗反应的模型预测概率截断值为0.678,AUC为0.739(95%CI 0.608-0.807)。

临床应用与阅片要点

  • 活动度评估可关注T1CE上外直肌信号强度比(LR-SIR)与DCE-MRI上下直肌流入率(IR-WIR),二者联合可提高评估效能。
  • 预测IVGC治疗反应可参考外直肌达峰时间(LR-TTP),有反应者LR-TTP较长。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the performance of contrast-enhanced orbital MRI (T1-weighted contrast-enhanced [T1CE] and dynamic contrast-enhanced MRI [DCE-MRI]) for activity assessment and prediction of treatment response to intravenous glucocorticoid (IVGC) treatment in thyroid eye disease (TED).

METHODS: A retrospective study of 59 active moderate-to-severe TED patients (36 responsive and 23 unresponsive) treated with IVGC, matched with 31 inactive TED patients were included. T1CE and DCE-MRI were collected from each subject. Univariate and multivariate logistic regression analyses, as well as receiver operating characteristic (ROC) curves (evaluated by area under the curve, AUC) were used to evaluate the diagnostic and predictive models.

RESULTS: Active patients showed a higher signal intensity ratio of lateral rectus (LR-SIR) on T1CE and a higher wash-in rate of inferior rectus (IR-WIR) on DCE-MRI compared to inactive patients (p < 0.05). The AUC for T1CE and DCE-MRI based models were 0.866, and 0.844, respectively. The combined model (LR-SIR and IR-WIR) significantly enhanced model performance (AUC = 0.914, 95 % CI: 0.858-0.970). Responsive patients demonstrated a longer time to peak of lateral rectus (LR-TTP) than unresponsive patients (p < 0.05). The cutoff value of prediction probability was 0.678, and the AUC based on this model was 0.739 (95 % CI: 0.608-0.807).

CONCLUSIONS: T1CE and DCE-MRI could effectively assist in TED activity assessment, and DCE-MRI could help predict IVGC treatment response. Specifically, LR-SIR and IR-WIR were indicators of TED activity, and IR-TTP was predictive of IVGC treatment response. Combining both contrast-enhanced sequences could further enhance the efficiency of TED activity assessment.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Xia D, Chew SP, Zhang H, et al. Contrast-enhanced orbital MRI for activity assessment and treatment response prediction in thyroid eye disease. Eur J Radiol. 2025. PMID: 40311273. doi:10.1016/j.ejrad.2025.112136

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。